Boston Scientific, headquartered in Marlborough, Massachusetts, develops and markets medical devices for interventional procedures across its MedSurg and Cardiovascular segments, employing 53,000 people. Key areas include Endoscopy, Urology, Neuromodulation, Cardiology, and Peripheral Interventions.
BSX has been in the news recently: Boston Scientific Corporation reported net sales of $5.061 billion in Q2 2025, reflecting a 22.8% increase, with a GAAP net income of $797 million or $0.53 per share. The company's strong sales performance and raised full-year guidance indicate positive momentum and potential for future product successes.
📡️ Health Care
In The News
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.